Valeo Pharma Inc. Class A share purchase warrants (VPH.WT.A) Fundamentals

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its products include Benztropine, Synacthen, M-Eslon, and others.
SHARE INFORMATION
Market Cap$ 172,500
Shares Outstanding2,875,000
Float2,875,000
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 13,557,000
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-10-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions-
Institutional Holdings Date-
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 0.06
52 Week Low$ 0.06
52 Week High Change$ 0.00
21 Day Moving Average$ 0.06
21 Day Extended Moving Average$ 0.06
50 Day Moving Average$ 0.06
50 Day Extended Moving Average$ 0.06
200 Day Moving Average$ 0.06
200 Day Extended Moving Average$ 0.06
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha-
Beta-
Standard Deviation-
R21
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 0.00
180 Day Percent Change0.0%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 0.00
Year to Date Percent Change0.0%

Valeo Pharma Inc. Class A share purchase warrants (VPH.WT.A) Key Ratios

PROFITABILITY
EBIT Margin-104.3%
EBITDA Margin-98.8%
Pre-Tax Profit Margin-150.5%
Profit Margin Count-58.55%
Gross Margin32.5%
Profit Margin TOT-58.55%
INCOME STATEMENTS
Revenue$ 15,082,000
Revenue Per Share$ 5.2459
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity37.63
Int Coverage-4.90
Current Ratio2.90
Leverage Ratio-12.80
Quick Ratio1.90
Long Term Debt To Capital0.97
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0
Price to Sales0.011437
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover1.30
Assets Turnover0.20
Return Assets-50.18
Return on Equity-1,600.41
Return on Capital-54.74

Valeo Pharma Inc. Class A share purchase warrants (VPH.WT.A) Profile

PROFILE INFO
Issue TypeWT
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOSteven Saviuk
Emplyoees100
Last AuditUE
CIK0000000000
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address16667, Hymus Boulevard
Kirkland, QC H9H 4R9
Websitehttps://www.valeopharma.com
Facsimile+1 514 694-0865
Telephone+1 514 693-8832
Email-
Your Recent History
TSX
VPH.WT.A
Valeo Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20221206 03:38:52